Search - tctmd.com

Displaying 101 - 120 of 176

Sort: Relevancy | Date

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Both High- and Low-Carb Diets Increase Long-term Risk of Mortality: ARIC Analysis

Lucy Hicks

August 30, 2018

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Todd Neale

August 26, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

Shelley Wood

July 27, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

CVD Prevention and Control Remains a Challenge in India

L.A. McKeown

June 26, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

L.A. McKeown

June 13, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

Advertisement

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Both High- and Low-Carb Diets Increase Long-term Risk of Mortality: ARIC Analysis

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Troubling Rise in CVD and Other Noncommunicable Disease in Tropical Nations

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

CVD Prevention and Control Remains a Challenge in India

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content